Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands
ConclusionsNTRK+ patients may have an increased risk of death compared withNTRK − patients. When using historic control data to assess the comparative effectiveness of TRK inhibitors, the prognostic value of theNTRK fusion biomarker should therefore be accounted for.
Source: Molecular Diagnosis and Therapy - Category: Molecular Biology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Colorectal Cancer | Genetics | Head and Neck Cancer | Molecular Biology | Netherlands Health | Neurology | Pancreas | Pancreatic Cancer | Skin | Study